These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26612030)

  • 21. Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates.
    Samuele A; Bisi S; Kataropoulou A; La Regina G; Piscitelli F; Gatti V; Silvestri R; Maga G
    Antivir Chem Chemother; 2011 Nov; 22(3):107-18. PubMed ID: 22095519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments.
    Brandt P; Geitmann M; Danielson UH
    J Med Chem; 2011 Feb; 54(3):709-18. PubMed ID: 21207958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction kinetic characterization of HIV-1 reverse transcriptase non-nucleoside inhibitor resistance.
    Geitmann M; Unge T; Danielson UH
    J Med Chem; 2006 Apr; 49(8):2375-87. PubMed ID: 16610781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.
    Ragno R; Artico M; De Martino G; La Regina G; Coluccia A; Di Pasquali A; Silvestri R
    J Med Chem; 2005 Jan; 48(1):213-23. PubMed ID: 15634015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase.
    Carlsson J; Boukharta L; Aqvist J
    J Med Chem; 2008 May; 51(9):2648-56. PubMed ID: 18410085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the protonation state in the interaction of an HIV-1 reverse transcriptase (RT) amino acid, Lys101, and a non nucleoside RT inhibitor, GW420867X.
    Galembeck SE; Bickelhaupt FM; Fonseca Guerra C; Galembeck E
    J Mol Model; 2014 Jul; 20(7):2332. PubMed ID: 24965933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Medina-Franco JL; Martínez-Mayorga K; Juárez-Gordiano C; Castillo R
    ChemMedChem; 2007 Aug; 2(8):1141-7. PubMed ID: 17477343
    [No Abstract]   [Full Text] [Related]  

  • 29. Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.
    Domaoal RA; Demeter LM
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1735-51. PubMed ID: 15183341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational approaches for the design of effective human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitors.
    Ribone SR; Quevedo MA; Madrid M; Briñón MC
    J Chem Inf Model; 2011 Jan; 51(1):130-8. PubMed ID: 21133347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking experiments in the flexible non-nucleoside inhibitor binding pocket of HIV-1 reverse transcriptase.
    Titmuss SJ; Keller PA; Griffith R
    Bioorg Med Chem; 1999 Jun; 7(6):1163-70. PubMed ID: 10428388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors.
    Geitmann M; Unge T; Danielson UH
    J Med Chem; 2006 Apr; 49(8):2367-74. PubMed ID: 16610780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A molecular-field-based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors. 2. The relationship between alignment solutions obtained from conformationally rigid and flexible matching.
    Mestres J; Rohrer DC; Maggiora GM
    J Comput Aided Mol Des; 2000 Jan; 14(1):39-51. PubMed ID: 10702924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor.
    Jaeger J; Restle T; Steitz TA
    EMBO J; 1998 Aug; 17(15):4535-42. PubMed ID: 9687519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification and regression trees--studies of HIV reverse transcriptase inhibitors.
    Daszykowski M; Walczak B; Xu QS; Daeyaert F; de Jonge MR; Heeres J; Koymans LM; Lewi PJ; Vinkers HM; Janssen PA; Massart DL
    J Chem Inf Comput Sci; 2004; 44(2):716-26. PubMed ID: 15032554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase.
    Ren J; Stammers DK
    Virus Res; 2008 Jun; 134(1-2):157-70. PubMed ID: 18313784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Monforte AM; Ferro S; De Luca L; Lo Surdo G; Morreale F; Pannecouque C; Balzarini J; Chimirri A
    Bioorg Med Chem; 2014 Feb; 22(4):1459-67. PubMed ID: 24457088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A check on rational drug design: molecular simulation of the allosteric inhibition of HIV-1 reverse transcriptase.
    Mager PP
    Med Res Rev; 1997 May; 17(3):235-76. PubMed ID: 9127858
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
    Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
    Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase.
    Tachedjian G; Orlova M; Sarafianos SG; Arnold E; Goff SP
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7188-93. PubMed ID: 11416202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.